Advertisement

Novavax Sells 60 Million Doses of Its Coronavirus Vaccine to the U.K. Government

Novavax Sells 60 Million Doses of Its Coronavirus Vaccine to the U.K. Government

In a Securities and Exchange Commission filing on Wednesday, Novavax (NASDAQ: NVAX) disclosed that the U.K. government had agreed to purchase 60 million doses of NVX-CoV2372, its COVID-19 vaccine candidate. The deal also gives the U.K. the option to make additional orders "from time to time." As part of the agreement, Novavax agreed to create a dedicated supply chain in the U.K. for the production of that country's order.